P. Flynn

465 total citations
12 papers, 320 citations indexed

About

P. Flynn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, P. Flynn has authored 12 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in P. Flynn's work include Cancer Treatment and Pharmacology (4 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). P. Flynn is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). P. Flynn collaborates with scholars based in United States and Vietnam. P. Flynn's co-authors include DC Arthur, DJ Weisdorf, WJ Miller, RF Branda, Richard D. Brunning, RW McKenna, RD Brunning, KJ Gajl-Peczalska, Suprith Badarinath and Zoneddy Dayao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

P. Flynn

11 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Flynn United States 6 178 135 82 74 56 12 320
Tadasu Tobita Japan 10 213 1.2× 206 1.5× 77 0.9× 42 0.6× 61 1.1× 12 381
Tania J. Curcio United States 8 195 1.1× 187 1.4× 81 1.0× 41 0.6× 41 0.7× 16 323
K Hirashima Japan 11 128 0.7× 152 1.1× 70 0.9× 177 2.4× 14 0.3× 34 419
Maoxiang Qian China 11 315 1.8× 189 1.4× 118 1.4× 54 0.7× 93 1.7× 43 516
Mariam Ibáñez Spain 9 245 1.4× 182 1.3× 49 0.6× 20 0.3× 46 0.8× 28 339
K Kagami Japan 10 165 0.9× 118 0.9× 71 0.9× 49 0.7× 85 1.5× 14 325
Paula de Melo Campos Brazil 11 147 0.8× 168 1.2× 69 0.8× 101 1.4× 34 0.6× 43 353
S Miyawaki Japan 6 164 0.9× 216 1.6× 32 0.4× 38 0.5× 43 0.8× 8 338
Yaozhong Zhao China 10 152 0.9× 219 1.6× 146 1.8× 26 0.4× 25 0.4× 20 314
Giulia Falconi Italy 13 189 1.1× 281 2.1× 46 0.6× 34 0.5× 30 0.5× 28 369

Countries citing papers authored by P. Flynn

Since Specialization
Citations

This map shows the geographic impact of P. Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Flynn more than expected).

Fields of papers citing papers by P. Flynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Flynn. The network helps show where P. Flynn may publish in the future.

Co-authorship network of co-authors of P. Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of P. Flynn. A scholar is included among the top collaborators of P. Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Flynn. P. Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Tan, Winston, Jacob B. Allred, P. Flynn, et al.. (2009). N0337: Phase II study of capecitabine in combination with vinorelbine and trastuzumab for the first or second treatment of HER2+ metastatic breast cancer. Journal of Clinical Oncology. 27(15_suppl). 1020–1020. 1 indexed citations
4.
Kozloff, M., John D. Hainsworth, Suprith Badarinath, et al.. (2007). 3049 POSTER Management of hypertension (HTN) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV) plus chemotherapy (CT). European Journal of Cancer Supplements. 5(4). 250–251. 12 indexed citations
5.
Sugrue, Mary M., M. Kozloff, John D. Hainsworth, et al.. (2007). 3048 POSTER Safety and effectiveness of bevacizumab (BV) plus chemotherapy (CT) in elderly patients with mCRC: results from the BRiTE registry. European Journal of Cancer Supplements. 5(4). 250–250. 7 indexed citations
6.
Pandya, K. J., Joseph A. Roscoe, Eduardo R. Pajon, et al.. (2004). A preliminary report of a double blind placebo controlled trial of gabapentin for control of hot flashes in women with breast cancer. A University of Rochester Cancer Center CCOP study. Journal of Clinical Oncology. 22(14_suppl). 8017–8017. 4 indexed citations
7.
Ball, Lynda, et al.. (2002). Expanding algebra by substituting CAS. 1 indexed citations
8.
McKenna, RW, DC Arthur, KJ Gajl-Peczalska, P. Flynn, & RD Brunning. (1985). Granulated T cell lymphocytosis with neutropenia: malignant or benign chronic lymphoproliferative disorder?. Blood. 66(2). 259–266. 65 indexed citations
9.
Flynn, P., et al.. (1983). Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood. 62(6). 1211–1217. 11 indexed citations
10.
Flynn, P., WJ Miller, DJ Weisdorf, et al.. (1983). Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood. 62(6). 1211–1217. 180 indexed citations
11.
Flynn, P., et al.. (1982). Treatment of acute promyelocytic leukemia with retinoic acid: Correlation with cell culture studies. 30(4). 2 indexed citations
12.
Flynn, P., Wendy S. Becker, & Daniel J. Weisdorf. (1980). A mechanism for reduction of experimental myocardial infarct size by ibuprofen. 7(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadasu Tobita Breakdown of academic impact, for papers by Tania J. Curcio Breakdown of academic impact, for papers by K Hirashima Breakdown of academic impact, for papers by Maoxiang Qian Breakdown of academic impact, for papers by Mariam Ibáñez Breakdown of academic impact, for papers by K Kagami Breakdown of academic impact, for papers by Paula de Melo Campos Breakdown of academic impact, for papers by S Miyawaki Breakdown of academic impact, for papers by Yaozhong Zhao Breakdown of academic impact, for papers by Giulia Falconi
Rankless by CCL
2026